María D.
Odero
Investigadora hasta 2024
Instituto de Investigación Sanitaria de Navarra
Pamplona, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria de Navarra (6)
2023
-
Activation of the PP2A-B56α heterocomplex synergizes with venetoclax therapies in AML through BCL2 and MCL1 modulation
Blood, Vol. 141, Núm. 9, pp. 1047-1059
-
Regulation and role of the PP2A-B56 holoenzyme family in cancer
Biochimica et Biophysica Acta - Reviews on Cancer, Vol. 1878, Núm. 5
-
Set Protein Is Involved in FLT3 Membrane Trafficking
Cancers, Vol. 15, Núm. 8
2020
-
The Role of MYC and PP2A in the Initiation and Progression of Myeloid Leukemias
Cells, Vol. 9, Núm. 3
2017
-
MYC-dependent recruitment of RUNX1 and GATA2 on the SET oncogene promoter enhances PP2A inactivation in acute myeloid leukemia
Oncotarget, Vol. 8, Núm. 33, pp. 53989-54003
2016
-
Protein phosphatase 2A as a therapeutic target in acute myeloid leukemia
Frontiers in Oncology, Vol. 6, Núm. APR